Clinical Trial Update: GW679769 In Fibromyalgia

View source ↗

Summary

Clinical trial of GW679769 for fibromyalgia has completed, with depressive disorders/depression listed as conditions evaluated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Fibromyalgia
• Major Depressive Disorder

Drugs mentioned

• GW679769

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder, Depression | Status: COMPLETED